Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Aceragen, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 20 | 3 | −17 |
| Shares | 165.4K | 4.35K | −161.0K (−97.4%) |
| Value | $269.5K | $22 | −$269.5K (−100.0%) |
New holders (0)
Institutions that held Aceragen, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (17)
Institutions that held Aceragen, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Vanguard Group Inc | 74,170 | $120.9K |
| BlackRock Inc. | 25,214 | $41.1K |
| Geode Capital Management, LLC | 23,342 | $38.0K |
| State Street Corp | 11,653 | $19.0K |
| Credit Agricole S A | 11,521 | $18.8K |
| Tower Research Capital LLC (TRC) | 7,126 | $11.6K |
| Morgan Stanley | 4,860 | $7.92K |
| UBS Group AG | 1,709 | $2.79K |
| Group One Trading, L.P. | 1,047 | $1.71K |
| The PNC Financial Services Group, Inc. | 191 | $311 |
| Bank of America Corp | 58 | $95 |
| Wells Fargo & Company | 36 | $59 |
| Advisor Group Holdings, Inc. | 30 | $48 |
| FMR LLC | 25 | $41 |
| Signaturefd, LLC | 11 | $18 |
| JPMorgan Chase & Co | 10 | $16 |
| NewSquare Capital LLC | 4 | $7 |